uniQure N.V. – Filings and Transcripts

NASDAQ: QURE
Share price (8/12/26): $45.13
Market cap (8/12/26): $3.131 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Aberdeen Group Plc

JPMorgan Chase & Co.

Kapusta Matthew C

Kapusta Matthew C

News Filter

Announces Second Quarter 2026 Financial Results and Provides Company Update

Announces Pricing of Upsized $225 Million Public Offering

Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy

~ 3-Year Analysis From the Phase I/II Study Can Serve as the Primary Basis of a Biologics License Application for Accelerated Approval With FDA ~ ~ Company Intends to Submit the BLA in Third Quarter of 2026 ~

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order